-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levoxiracetam in Memory Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levoxiracetam in Memory Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levoxiracetam in Memory Impairment Drug Details: L-oxiracetam is under development for the...
-
Product Insights
Memory Impairment – Drugs In Development, 2023
Global Markets Direct’s, ‘Memory Impairment - Drugs In Development, 2023’, provides an overview of the Memory Impairment pipeline landscape. The report provides comprehensive information on the therapeutics under development for Memory Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Micron Technology – Boise Memory Chip Manufacturing Plant – Idaho
The Micron Technology – Boise Memory Chip Manufacturing Plant – Idaho project involves the construction of a semiconductor manufacturing facility in the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Micron Technology – Boise Memory Chip Manufacturing Plant – Idaho report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain...
-
Company Insights
Innovation and Patenting activity of AP Memory Technology Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of AP Memory Technology Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval Analysis for Dementia Associated With Alzheimer’s Disease
Overview How likely is it that the drugs in Dementia Associated With Alzheimer's Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dementia Associated With Alzheimer's Disease Overview Alzheimer's disease (AD)...
-
Product Insights
NewLikelihood of Approval Analysis for Dementia
Overview How likely is it that the drugs in Dementia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dementia Overview Dementia is the decline in cognitive abilities that impacts a person's...
-
Product Insights
NewLikelihood of Approval Analysis for Fibromyalgia (Fibromyalgia Syndrome)
Overview How likely is it that the drugs in Fibromyalgia (Fibromyalgia Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fibromyalgia (Fibromyalgia Syndrome) Overview Fibromyalgia is a disorder characterized by widespread...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-Viral Central Memory CD8 Veto Cells in Bone Marrow Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-Viral Central Memory CD8 Veto Cells in Bone Marrow Transplant Rejection report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-Viral Central Memory CD8...